ICD-11 classes
06 Mental, behavioural or neurodevelopmental disorders
07 Sleep-wake disorders
Sleep-related breathing disorders
7A40 — Central sleep apnoeas
7A40.6 — Central sleep apnoea due to a medication or substance
ICD-11 7A40.6 — Central sleep apnoea due to a medication or substance
Central sleep apnoea due to a medication is characterised by a pattern of recurring, predominantly central sleep apnoea or hypopnoea (more than five per hour) that is attributable to a medication or substance, most commonly long-acting opioids (e.g. methadone, long-acting morphine or oxycodone, fentanyl patches). The disturbance is sufficiently severe to cause symptoms such as daytime sleepiness, disturbed sleep, awakening with dyspnoea, or snoring. Obstructive apnoeas and hypoventilation may be present, but central sleep apnoea is the predominant finding.Note: A definitive diagnosis requires objective evidence based on polysomnography in the context of medication or substance use that is judged to be causing the symptoms.
The diagnosis includes nothing.
The diagnosis excludes nothing.
It has no clarifying diagnoses.
The diagnosis is coded elsewhere:
- Central sleep apnoeas #6531
- Central sleep apnoeas #13218